Mycoplasma gallisepticum in Poultry: Clinical Signs, Diagnosis, and Control Strategies

Introduction

Mycoplasma gallisepticum (MG) is a major bacterial pathogen of poultry worldwide, responsible for chronic respiratory disease (CRD) in chickens and infectious sinusitis in turkeys. The organism is a cell-wall-deficient mollicute that colonizes the respiratory epithelium, leading to significant economic losses through reduced egg production, increased feed conversion ratios, and elevated mortality when exacerbated by co-infecting agents. MG infection is frequently complicated by concurrent viral or bacterial pathogens such as Avian Influenza A(H5N1) in Poultry and Wild Birds (avian influenza H5N1 page), Avian Pathogenic Escherichia coli (APEC) (APEC page), or Newcastle disease virus. The pathogen also exhibits complex interactions within the upper respiratory tract microbiome, as demonstrated by Rodrigo et al. [1] in commercial free-range layers, where co-infection with multiple agents modulates clinical severity.

This article provides a comprehensive review of the clinical presentation, diagnostic approaches, and control strategies for MG in poultry, with emphasis on molecular detection, serological surveillance, and vaccination protocols. The content is intended for veterinary diagnosticians, poultry health specialists, and researchers in computational biology who require mechanistic detail on pathogen biology and assay physics.

Etiology and Pathogenesis

M. gallisepticum is a facultative anaerobe that lacks a peptidoglycan cell wall, rendering it intrinsically resistant to beta-lactam antibiotics. Its small genome (approximately 1.0 Mb) encodes a repertoire of surface lipoproteins, including the GapA and CrmA adhesins, which mediate attachment to ciliated respiratory epithelial cells. The organism induces ciliostasis, mucosal inflammation, and infiltration of lymphocytes and macrophages. Chronic infection leads to lymphoid follicle formation and airsacculitis. The pathogen can also evade host immune responses through antigenic variation of the VlhA gene family, complicating serological diagnosis and vaccine design.

Transmission occurs horizontally via aerosolized respiratory droplets and vertically through the egg (transovarian transmission). The incubation period ranges from 6 to 21 days depending on strain virulence, host immune status, and environmental stressors.

Clinical Signs in Chickens and Turkeys

In chickens, MG classically presents as chronic respiratory disease (CRD) characterized by:

• Nasal discharge and ocular exudates
• Sneezing, coughing, and tracheal rales
• Reduced feed intake and weight gain
• Decreased egg production (10–30 % drop)
• Increased embryonic mortality and reduced hatchability

In turkeys, MG causes infectious sinusitis with pronounced infraorbital sinus swelling, purulent exudation, and dyspnea. Clinical expression is often mild in the absence of secondary pathogens; however, co-infection with APEC or infectious bronchitis virus markedly exacerbates lesions. A cross-sectional study by Rodrigo et al. [1] in free-range layers demonstrated that MG-positive flocks frequently harbor multiple respiratory pathogens, and the presence of co-infecting agents is a stronger predictor of clinical disease than MG detection alone. Similarly, Hartady et al. [2] reported a case of avian influenza co-infection in a broiler farm where MG contributed to a multifactorial disease complex, underscoring the synergistic pathology.

Subclinical infection is common and contributes to silent transmission. Behavioral changes, such as reduced movement and increased resting time, have been associated with infection; Adelman et al. [3] found that host populations with longer co-evolutionary history with MG exhibit higher behavioral tolerance, meaning that birds may not display overt sickness behavior despite being infected. This has implications for passive surveillance based on visual observation.

A summary of clinical signs by production stage is provided in Table 1.

Table 1. Clinical Signs of Mycoplasma gallisepticum Infection in Chickens and Turkeys

Diagnostic Methods

Accurate diagnosis of MG relies on a combination of pathogen detection (molecular, culture) and serological evidence of exposure. The choice of assay depends on the purpose: flock screening, confirmation of clinical cases, differentiation of vaccine from wild-type strains, or surveillance for eradication programs.

Molecular Detection

Nucleic acid amplification tests (NAATs) are the gold standard for MG detection. Conventional PCR targeting the 16S rRNA gene or the mgc2 gene is widely used, but real-time quantitative PCR (qPCR) offers greater sensitivity and quantification. Fan et al. [4] developed a duplex qPCR assay that distinguishes MG from Mycoplasma synoviae using strain-specific primers and probes, achieving a limit of detection below 10 genomic copies per reaction. This assay is particularly useful for vaccine efficacy monitoring where co-infection with M. synoviae may occur.

A multiplex TaqMan real-time PCR assay reported by Xin et al. [5] differentiates wild-type MG from vaccine strains (such as ts-11, 6/85, and F-strain) by targeting single nucleotide polymorphisms in the gapA gene. This capability is critical for interpreting positive PCR results in vaccinated flocks, as vaccine strains can persist and be detected by standard assays.

Isothermal amplification methods have gained attention for field deployment. Jing et al. [6] described a high-throughput colorimetric loop-mediated isothermal amplification (LAMP) assay that uses a pH-sensitive dye for visual readout and can be analyzed with intelligent algorithms (machine learning classifiers) to improve throughput and objectivity. Mayne et al. [7] further validated a field-ready colorimetric LAMP assay that uses a rapid DNA extraction protocol (boiling with Chelex resin), eliminating the need for column-based purification. This assay demonstrated 100 % concordance with qPCR on clinical samples from chickens.

Serological Methods

Serology remains the backbone of flock-level surveillance. The most common platforms are:

• Serum plate agglutination (SPA): rapid, inexpensive, but prone to false positives from non-specific agglutination and cross-reactivity with other Mycoplasma species.
• Hemagglutination inhibition (HI): more specific, but labor-intensive and strain-dependent.
• Commercial enzyme-linked immunosorbent assay (ELISA) kits (ELISA for FeLV reference for general principles) are widely used for high-throughput screening. ELISAs detect antibodies against MG lipoproteins, but cannot differentiate vaccinated from infected animals unless paired with a DIVA (differentiating infected from vaccinated animals) strategy.

A summary of diagnostic methods is presented in Table 2.

Table 2. Diagnostic Techniques for Mycoplasma gallisepticum in Poultry

Acoustic and Computational Methods

Emerging non-invasive diagnostic approaches include acoustic recognition. Guo et al. [8] applied a multi-noise separation algorithm to recorded vocalizations of chickens, using acoustic features to detect MG-associated respiratory symptoms. The method achieved over 85 % classification accuracy in experimental settings and may serve as a supplementary surveillance tool in commercial houses.

Control Strategies

Control of MG relies on three pillars: biosecurity and management, vaccination, and antimicrobial therapy. Antimicrobial resistance is a growing concern, and alternative control agents are under investigation.

Biosecurity and Management

Prevention of introduction through all-in/all-out production, isolation of replacement stock, and stringent sanitation of equipment and housing are fundamental. Vertical transmission is reduced by sourcing eggs from MG-free breeder flocks. Monitoring programs using serological testing of sentinel birds and periodic PCR of tracheal swabs are recommended. Comprehensive guidelines are provided by the World Organisation for Animal Health (WOAH) (WOAH informatics reference).

Vaccination

Both live attenuated and recombinant vector vaccines are available. Live vaccines (F-strain, ts-11, 6/85) reduce clinical signs and egg production losses but can persist in flocks and interfere with serological monitoring. Hashish et al. [9] evaluated vaccination programs in layer pullets using a recombinant fowlpox virus vectored MG vaccine (rFP-MG) and compared it to commercially available F-strain live vaccines. The rFP-MG vaccine induced comparable antibody titers and protection against challenge, with the advantage of not causing false-positive reactions in serological tests, providing a DIVA capability.

Strain-specific molecular assays, such as those described by Fan et al. [4] and Xin et al. [5], are essential for vaccine surveillance. They enable diagnosticians to confirm whether a detected strain is vaccine-derived or a field infection, informing strategic vaccination decisions and outbreak response.

Antimicrobial Therapy and Alternative Agents

Antimicrobials commonly used against MG include tylosin, tilmicosin, oxytetracycline, and enrofloxacin. However, Morrow et al. [10] documented increasing antimicrobial resistance (AMR) in MG isolates from poultry, particularly to macrolides and tetracyclines. The study highlighted the need for prudent antibiotic use and surveillance of resistance patterns through minimum inhibitory concentration testing. The broader issue of AMR in livestock-associated bacteria is discussed in the article antimicrobial resistance in livestock-associated Staphylococcus aureus.

Several non-antibiotic alternatives have been investigated. Yan et al. [11] evaluated four Chinese herbal medicine formulations for preventing and treating MG infection in chickens, reporting reduced clinical scores and tracheal lesion severity compared to untreated controls, though the mechanisms remain incompletely understood. Xu et al. [12] explored the mechanism of Scutellaria baicalensis extracellular vesicles, which attenuated MG-induced inflammation in chicken tracheal epithelial cells by inhibiting the TRPC1-STIM1/ORAI1 calcium channel pathway. This represents a novel host-directed therapeutic approach.

Zidi et al. [13] demonstrated that Spirulina platensis extract exhibits antimicrobial activity against macrolide-resistant MG isolates in vitro, likely through disruption of membrane integrity. Another novel class of compounds, cyclometalated palladium complexes, was evaluated by Vishnyakov et al. [14] and showed potent antimycoplasmatic activity with low cytotoxicity in cell culture, offering a potential future chemotherapeutic option.

Diagnostic and Control Decision Workflow

A flowchart for integrating diagnostic testing into control decisions is presented in Figure 1.

flowchart TD
    A[Flock with respiratory signs or egg drop], > B[Collect tracheal swabs and serum samples]
    B, > C{Initial screening}
    C, >|SPA or ELISA positive| D[Confirm with real-time qPCR]
    C, >|SPA or ELISA negative| E[No MG detected; investigate other pathogens]
    D, > F{Strain identification}
    F, >|Multiplex TaqMan assay| G[Vaccine strain or wild-type?]
    G, >|Vaccine strain| H[Monitor; no action needed]
    G, >|Wild-type| I[Implement biosecurity & treatment]
    I, > J[Antimicrobial susceptibility testing]
    J, > K[Select antibiotic or alternative therapy]
    K, > L[Post-treatment re-testing by qPCR]
    L, > M[Clearance confirmed?]
    M, >|Yes| N[Continue surveillance]
    M, >|No| O[Review therapy; consider culling]
    D, >|No detection| P[Rule out MG; consider other pathogens]
    P, > Q[Avian influenza, NDV, APEC, IBV]
    Q, > R[Refer to respective diagnostic protocols]

This workflow emphasizes the importance of strain differentiation for vaccine management and the need for AST to guide therapy in the face of rising AMR.

Conclusions

Mycoplasma gallisepticum remains a persistent threat to global poultry production, requiring integrated diagnostic and control strategies. Advances in molecular diagnostics, including duplex qPCR, multiplex vaccine-strain differentiation, and field-ready colorimetric LAMP, have enhanced the precision of pathogen identification and surveillance. Vaccination with recombinant vector vaccines offers DIVA compatibility, while novel anti-mycoplasmal agents such as plant-derived extracellular vesicles and metal complexes represent emerging alternatives amid growing antimicrobial resistance. Continued research into the complex pathogen interactions in the respiratory tract, as illustrated by the work of Rodrigo et al. [1] and Hartady et al. [2], will further refine risk assessment and mitigation strategies.

References

[1] Rodrigo CH, Kulappu Arachchige SN, Bushell RN, et al. Complex pathogen interactions in upper respiratory tract infections in commercial free-range layers: A cross-sectional study. Vet Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42190304/

[2] Hartady T, Sugandi SD, Viqih M. A Case of Avian Influenza Co-Infection and Multifactorial Diseases in a Broiler Chicken Farm in Majalengka, West Java, Indonesia. Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42076736/

[3] Adelman JS, Henschen AE, Tillman FE Jr, et al. The devil you know: a longer history of pathogen coevolution predicts higher behavioural tolerance of infection among host populations. Biol Lett. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42124517/

[4] Fan P, Liu Z, Xu Y, et al. Strain-specific detection of Mycoplasma gallisepticum: A duplex qPCR assay for vaccine efficacy and infection surveillance. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42139893/

[5] Xin J, Zhang J, Liang S, et al. A multiplex TaqMan real-time PCR assay for differential identification of wild-type and vaccine strains of Mycoplasma gallisepticum. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41702344/

[6] Jing W, Cai Q, Liang Y, et al. High-throughput colorimetric LAMP detection of Mycoplasma gallisepticum with intelligent algorithm-assisted analysis. Anal Methods. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41891257/

[7] Mayne R, Pant SD, Huang J, et al. A field-ready colourimetric LAMP assay for detection of Mycoplasma gallisepticum using rapid DNA extraction. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41785617/

[8] Guo X, Shi L, Li J, et al. Chicken disease detection and localization using multi-noise separation and acoustic recognition. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42056823/

[9] Hashish A, Chaves M, Osemeke O, et al. Evaluation of Vaccination Programs in Layer Pullets Using Recombinant Fowl-Pox Mycoplasma gallisepticum Vaccine in Comparison to Commercially Available F-Strain Live Vaccines. Avian Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41973009/

[10] Morrow CJ, Achari RA, Charles M, et al. Mycoplasma, antibiotics in lay, and antimicrobial resistance (AMR). Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42139894/

[11] Yan Y, Liao L, Fan Y, et al. Evaluation and Analysis of the Efficacy of Four Chinese Herbal Medicines and Formulations in Preventing and Treating Mycoplasma gallisepticum Infection in Chickens. Vet J. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42191062/

[12] Xu F, Bao L, Yao Y, et al. Mechanism of Scutellaria baicalensis extracellular vesicles in attenuating Mycoplasma gallisepticum-induced inflammation via TRPC1 - STIM1/ORAI1 channel inhibition. Poult Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41905072/

[13] Zidi S, Khadraoui N, Essid R, et al. Spirulina platensis as a novel natural antimicrobial against macrolide-resistant Mycoplasma gallisepticum in poultry. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41788330/

[14] Vishnyakov IE, Plekhanov AY, Goodkov AV, et al. Cyclometalated palladium complexes as promising antimycoplasmatic drugs. Naunyn Schmiedebergs Arch Pharmacol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41711837/

[15] Wang W, Wu J, Legnardi M, et al. Editorial: Epidemiology and control of emerging/re-emerging poultry and waterfowl diseases. Front Microbiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42063502/